Genesco (GCO) Projected to Release Quarterly Earnings on Thursday

Key Points

• Genesco is expected to report Q2 fiscal 2027 results before the market opens on August 27, 2026. Analysts forecast a loss of $1.34 per share on revenue of $528.4 million; the company’s full-year EPS guidance is $2.00–$2.40.
• In its latest quarter, Genesco reported a loss of $2.18 per share, beating expectations for a $2.58 loss, while revenue of $487.03 million exceeded the $474.32 million consensus estimate.
• Analyst sentiment is cautious: the stock has a consensus “Hold” rating and an average price target of $36.67, compared with a recent price of $34.98. Institutional investors own 94.51% of shares, while insiders own 23.11%.

Genesco (NYSE:GCO - Get Free Report) is anticipated to post its Q2 2027 results before the market opens on Thursday, August 27th. Analysts expect Genesco to announce earnings of ($1.34) per share and revenue of $528.40 million for the quarter. Genesco has set its FY 2027 guidance at 2.000-2.400 EPS. Interested persons may review the information on the company's upcoming Q2 2027 earning summary page for the latest details on the call scheduled for Thursday, August 27, 2026 at 8:30 AM ET.

Genesco (NYSE:GCO - Get Free Report) last issued its quarterly earnings data on Friday, May 29th. The company reported ($2.18) earnings per share for the quarter, beating analysts' consensus estimates of ($2.58) by $0.40. The company had revenue of $487.03 million during the quarter, compared to analysts' expectations of $474.32 million. Genesco had a return on equity of 2.66% and a net margin of 0.80%. On average, analysts expect Genesco to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Genesco Price Performance

GCO stock opened at $34.98 on Thursday. The company has a current ratio of 1.83, a quick ratio of 0.37 and a debt-to-equity ratio of 0.08. The company has a market capitalization of $388.68 million, a P/E ratio of 20.22 and a beta of 1.83. The business has a 50 day simple moving average of $36.14 and a 200-day simple moving average of $32.93. Genesco has a twelve month low of $21.92 and a twelve month high of $43.60.

Insider Activity at Genesco

In related news, Director Gregory A. Sandfort purchased 2,958 shares of the business's stock in a transaction dated Thursday, July 9th. The stock was acquired at an average price of $33.80 per share, for a total transaction of $99,980.40. Following the completion of the purchase, the director directly owned 29,172 shares of the company's stock, valued at $986,013.60. This trade represents a 11.28% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 23.11% of the stock is owned by company insiders.

Hedge Funds Weigh In On Genesco

Several institutional investors have recently bought and sold shares of the company. Arrowstreet Capital Limited Partnership grew its holdings in Genesco by 371.2% during the second quarter. Arrowstreet Capital Limited Partnership now owns 272,455 shares of the company's stock worth $5,365,000 after acquiring an additional 214,639 shares during the period. Shay Capital LLC acquired a new stake in Genesco in the second quarter valued at $4,027,000. JPMorgan Chase & Co. lifted its holdings in Genesco by 2,995.5% in the third quarter. JPMorgan Chase & Co. now owns 167,155 shares of the company's stock valued at $4,846,000 after acquiring an additional 161,755 shares during the period. MUFG Securities EMEA plc acquired a new stake in Genesco in the second quarter valued at $2,954,000. Finally, Marshall Wace LLP boosted its position in shares of Genesco by 232.5% during the 4th quarter. Marshall Wace LLP now owns 174,218 shares of the company's stock worth $4,315,000 after purchasing an additional 121,814 shares in the last quarter. 94.51% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

GCO has been the subject of a number of recent research reports. Wall Street Zen cut shares of Genesco from a "buy" rating to a "hold" rating in a research note on Saturday, June 13th. Zacks Research lowered shares of Genesco from a "strong-buy" rating to a "hold" rating in a research note on Friday, July 31st. Weiss Ratings cut shares of Genesco from a "hold (c)" rating to a "sell (d+)" rating in a report on Friday, June 12th. Truist Financial set a $40.00 target price on shares of Genesco in a research note on Friday, May 29th. Finally, Seaport Research Partners downgraded shares of Genesco from a "buy" rating to a "neutral" rating in a research note on Wednesday, May 27th. One investment analyst has rated the stock with a Strong Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $36.67.

Genesco Company Profile

Genesco Inc is a Nashville, Tennessee-based retailer, wholesaler and licensee specializing in branded footwear, headwear, apparel and accessories. Through its portfolio of retail chains, wholesale distribution channels and licensing agreements, Genesco brings a range of product offerings to consumers in North America and Europe.

The company's retail segment includes specialty chains such as Journeys, which targets fashion-focused teens and young adults in the United States and Canada, and Schuh, a footwear retailer with locations in the United Kingdom and Ireland.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source